Design of nanocarriers based on complex biological barriers in vivo for tumor therapy
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Nanoscale drug delivery systems (NDDS) have shown great potential in tumor treatment due to its unique advantages, especially its unique enhanced permeability and retention effect (EPR) in solid tumors. Therefore, NDDS have been extensively explored in recent years. However, current NDDS did not achieve satisfied clinical therapeutic effect against to tumor treatment. This is mainly ascribed to two reasons. One is that nanocarriers would inevitably encounter a series of physiological and pathological barriers in vivo, leading to low drug transport efficiency. The other is that tumor stroma pose a huge obstruction to tumor therapy, nanotherapeutics just focus on the tumor cells themselves are insufficient for complete tumor eradication. Here in this review, we first outlining sequential biological obstacles encountered by nanocarriers from three levels of blood, tumor tissue and tumor cells. Then, we give a detailed discussion of the role of tumor stroma, and highlight the therapeutic resistances mediated by tumor stroma. In light of these formidable barriers, we provide promising approaches to overcome each barrier or remodel stroma through innovative NDDS design. Finally, we give proposals and considerations of NDDS design, and then discuss several existing challenges and further opportunities of NDDS in clinical application. This review seeks to provide guidelines for optimizing NDDS design through mitigation of biological barriers to efficient tumor therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229
Cited by
Liang, S., Deng, X., Chang, Y., Sun, C., Shao, S., Xie, Z., Xiao, X., Ma, P., Zhang, H., Cheng, Z., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01595 · Cited by 436
Wang, Y., Zhang, K., Li, T., Maruf, A., Qin, X., Luo, L., Zhong, Y., Qiu, J., McGinty, S., Pontrelli, G., et al. (2021) · Theranostics · doi:10.7150/thno.47841 · Cited by 409
Multi-Stimuli-Responsive Polymer Particles, Films, and Hydrogels for Drug Delivery
Fu, X., Hosta-Rigau, L., Chandrawati, R., & Cui, J. (2018) · Chem · doi:10.1016/j.chempr.2018.07.002 · Cited by 381
Biomedical Micro‐/Nanomotors: From Overcoming Biological Barriers to In Vivo Imaging
Gao, C., Wang, Y., Ye, Z., Lin, Z., Ma, X., & He, Q. (2021) · Advanced Materials · doi:10.1002/adma.202000512 · Cited by 358
Wang, Y., Zhang, K., Qin, X., Li, T., Qiu, J., Yin, T., Huang, J., McGinty, S., Pontrelli, G., Ren, J., et al. (2019) · Advanced Science · doi:10.1002/advs.201900172 · Cited by 314
Metadata
- Authors
- Liu, J., Li, M., Luo, Z., Dai, L., Guo, X., & Cai, K.
- Venue
- Nano Today
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 15
- Pages
- 56-90
- ISSN
- 1748-0132 (ISSN-L)
- OpenAlex
- W2743734728
- Cited by
- 157
- References
- 54
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Design of nanocarriers based on complex biological barriers in vivo for tumor therapy. https://app.cochat.ai/papers/10.1016/j.nantod.2017.06.010
- The paper
- Liu, J., Li, M., Luo, Z., Dai, L., Guo, X., & Cai, K. (2017). Design of nanocarriers based on complex biological barriers in vivo for tumor therapy. Nano Today. https://doi.org/10.1016/j.nantod.2017.06.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.